C

Concord Biotech Ltd

PharmaceuticalsSmallcap

About the company

Concord Biotech Limited, a biopharma company, engages in R&D, manufacturing, and marketing of pharmaceutical products in diverse therapeutic segments.

Performance

Stock
Loading Stock value

Analyst Ratings and Key Metrics

Based on 5 analysts offering recommendations for Concord Biotech Ltd

80%

Buy

20%

Hold

0%

Sell

Key MetricsThis StockCategory (Avg)
PE Ratio58.2946.16
PB Ratio7.555.78
Dividend Yield0.52%0.49%

Understand what these metrics mean. 

Equity investments are subject to market risks. Read all the related documents carefully before investing. By using this page, you agree to the Terms & Conditions